ARCHIVE

• Combination Therapies to Be Approved for 5 Types of Cancer
  December 13, 2004

• Aredia Approved for Osteoclastic Bone Metastasis of Breast Cancer
  December 13, 2004

• Final ICH Agreement Reached on Pharmacovigilance Planning: Korosho
  December 13, 2004

• NWE PRODUCTS
  December 13, 2004

• REGULATORY NEWS IN BRIEF
  December 13, 2004

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  December 13, 2004

• Rohto Develops World's 1st DDS Technology for Stable Alginic Acid Eye Drops
  December 13, 2004

• Sales of 26 Leading JPMA Firms Up 0.5%
  December 6, 2004

• Semi-annual Business Results
  December 6, 2004

• Semi-annual Business Results
  December 6, 2004

• Top 28 Post 0.1% Decline in Non-consolidated Sales
  December 6, 2004

• VITAL-NET: Profits Down Sharply Despite Growth in Sales
  December 6, 2004

• Japan Should Boost Healthcare Spending to 9% of GDP: Mr Butler of PhRMA
  December 6, 2004

• SSP: Sales of Rx Drugs Up 6.1% to \5.8 Bil.
  December 6, 2004

• NEW PRODUCTS
  December 6, 2004

• SSP to Concentrate on Consumer Healthcare: VP Yamashita
  December 6, 2004

• Wyeth's Enbrel Receives Import Approval
  December 6, 2004

• Zeria: Sales Up 4.2% to \28,486 Mil.
  December 6, 2004

• Expanding Indications for Cancer Combination Therapy Approved
  December 6, 2004

• Fuso: Drug Sales, Up 0.5% to \20.6 Bil.
  December 6, 2004

ページ

• « 先頭
• ‹ Prev
• …
• 493
• 494
• 495
• 496
• 497
• 498
• 499
• 500
• 501
• …
• Next ›
• 最終 »